SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015801
Filing Date
2018-11-13
Accepted
2018-11-13 17:29:15
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 864262
2 ex31-1.htm EX-31.1 17833
3 ex31-2.htm EX-31.2 17998
4 ex32.htm EX-32 5416
  Complete submission text file 0001493152-18-015801.txt   4882986

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE brtx-20180930.xml EX-101.INS 870331
6 XBRL SCHEMA FILE brtx-20180930.xsd EX-101.SCH 55630
7 XBRL CALCULATION FILE brtx-20180930_cal.xml EX-101.CAL 50567
8 XBRL DEFINITION FILE brtx-20180930_def.xml EX-101.DEF 264611
9 XBRL LABEL FILE brtx-20180930_lab.xml EX-101.LAB 394203
10 XBRL PRESENTATION FILE brtx-20180930_pre.xml EX-101.PRE 338359
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 181179318
SIC: 8090 Services-Misc Health & Allied Services, NEC
Assistant Director 9